BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders

Karacetin, G.; Bayoglu, Burcu; Soylemez, T.; Topal, M.; Koc, E.; Tekden, M.; Ermis, C.; Demir, Türkay; Yuksel, M.; Ercan, E.; Erkiran, M.; Sezgin, S.; Cengiz, M.

doi:10.1016/j.ejpsy.2021.04.002

BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders

Karacetin G., Bayoglu B., Soylemez T. E., Topal M., Koc E. B., Tekden M., ...Daha Fazla

EUROPEAN JOURNAL OF PSYCHIATRY, cilt.36, sa.1, ss.26-34, 2022 (SSCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36 Sayı: 1
Basım Tarihi: 2022
Doi Numarası: 10.1016/j.ejpsy.2021.04.002
Dergi Adı: EUROPEAN JOURNAL OF PSYCHIATRY
Derginin Tarandığı İndeksler: Social Sciences Citation Index (SSCI), Scopus, ASSIA, BIOSIS, EMBASE, Psycinfo, DIALNET
Sayfa Sayıları: ss.26-34
Anahtar Kelimeler: DRD2/ANKK1 Taq1A genotypes, BDNF Val66Met genotypes, Early-onset schizophrenia, NEUROTROPHIC FACTOR BDNF, D2 RECEPTOR GENE, SERUM-LEVELS, TAQ1A POLYMORPHISM, NO ASSOCIATION, CANNABIS USE, KINASE GENE, DRD2, METAANALYSIS, RISK
İstanbul Üniversitesi Adresli: Evet

Özet

Background and Objectives: To investigate the clinical characteristics of adolescents with early-onset full psychotic disorders either with Brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) or DRD2/ANKK1 Taq1A (rs1800497) polymorphisms.